Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: Arm I: Participants identified as Vali thegi will receive Madhumega Chooranam Mathirai 500 mg two tablets twice a day before food with warm water and along with standard care Oral hypog
Sponsors
Central Council for Research in Siddha
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged 20 to 70 years with a confirmed diagnosis of T2DM Fasting Blood Glucose FBS greater than or equal to 126 mg per dL and or Postprandial Blood Glucose PPBS greater than or equal to 200 mg per dL HbA1c levels between greater than or equal to 6 and half percent and 10 percent Patients under the baseline treatment or standard care Willingness to comply with the study protocol
Exclusion criteria
Exclusion criteria: Patients with Type 1 Diabetes Mellitus or other endocrine disorders Individuals with severe complications of diabetes such as nephropathy retinopathy or neuropathy Pregnant or lactating women Patients on insulin therapy or other herbal medications for diabetes management
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the efficacy of Madhumega Chooranam Mathirai MCM in reducing blood Glucose levels in diabetes mellitus patients attending SCRU Tirupati based on three body constitution through Yakkai IlakkanamTimepoint: Baseline 0 Day 15 Day 30 Day 45 Day 60 Day 75 Day 90 Day 105 Day 120 Followup Day 150 and Day 180 | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate the safety of the Madhumega Chooranam Mathirai MCM in diabetes mellitus patients attending SCRU Tirupati by measuring liver function and renal function testsTimepoint: Baseline 0 Day 90 Day 120 | — |
Countries
India
Contacts
Public ContactR Tamilselvan
Siddha Clinical Research Unit
Outcome results
None listed